mirtazapine has been researched along with Impaired Glucose Tolerance in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hennings, JM | 1 |
| Ising, M | 1 |
| Grautoff, S | 1 |
| Himmerich, H | 1 |
| Pollmächer, T | 1 |
| Schaaf, L | 1 |
1 other study available for mirtazapine and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Glucose tolerance in depressed inpatients, under treatment with mirtazapine and in healthy controls.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Area Under Curve; Depressive Disorder; Female; Glucos | 2010 |